BACKGROUND Depression is a widespread mental health condition that requires effective treatment.In the treatment of depression,traditional Chinese medicine(TCM)offers obvious advantages,fewer adverse reactions,and a l...BACKGROUND Depression is a widespread mental health condition that requires effective treatment.In the treatment of depression,traditional Chinese medicine(TCM)offers obvious advantages,fewer adverse reactions,and a lower recurrence rate.AIM To evaluate the clinical benefits of Guipi decoction combined with escitalopram oxalate tablets for individuals with depression.METHODS In total,80 patients diagnosed as having depression were enrolled in the study and divided into either an experimental group or a control group.All of the patients were orally administered escitalopram oxalate tablets.Additionally,the experimental group received Jiajian Guipi decoction and reduced Governor vessel fumigation over 4 wk.TCM syndrome scores,Hamilton depression rating scale(HAM-D)scores,self-rating depression scale(SDS)scores,and Pittsburgh sleep quality index scores were measured for the two groups and compared before and after the treatment.The two groups were monitored for any adverse reactions.RESULTS After 4 wk of treatment,both groups exhibited a significant reduction in TCM syndrome scores compared with their pre-treatment scores(P<0.05).However,the experimental group exhibited significantly lower TCM syndrome scores than the control group(P<0.05).Similarly,the post-treatment SDS and HAM-D-24 scores were significantly lower in both groups than the pre-treatment scores(P<0.05),with the experimental group exhibiting lower scores than the control group(P<0.05).The total treatment efficiency was significantly better in the experimental group(97.14%)than in the control group(77.78%)(P<0.05).Furthermore,after 4 wk of treatment,the Pittsburgh sleep quality index scores for both groups were significantly lower than those before the treatment(P<0.05),with the experimental group exhibiting lower scores than the control group(P<0.05).The incidence of adverse reactions was significantly lower in the experimental group than in the control group(P<0.05).CONCLUSION The combination of Guipi decoction and escitalopram oxalate tablets was found to be an effective and safe treatment for depression.This combination could reduce TCM syndrome scores,improve depressive symptoms,and enhance sleep quality.展开更多
目的:观察加减四磨汤治疗慢性便秘气滞型(Chronic Constipation of Stagnation of QI,CCSQ)的疗效和安全性。方法:将95例CCSQ患者随机分成A组(加减四磨汤治疗组),B组(普卢卡必利对照组),首要观察12周治疗后自然完全排便次数(Spontaneous...目的:观察加减四磨汤治疗慢性便秘气滞型(Chronic Constipation of Stagnation of QI,CCSQ)的疗效和安全性。方法:将95例CCSQ患者随机分成A组(加减四磨汤治疗组),B组(普卢卡必利对照组),首要观察12周治疗后自然完全排便次数(Spontaneous,Complete Bowel Movements,SCBM)≥3次/周的比例,次要观察SCBM增加≥1次/周的患者比例,并比较入组前及第4、6、12周便秘患者生活质量量表(Patient Assessment of Constipation Quality of Life,PAC-QOL)。同时记录不良事件。结果:在12周的疗程中,A组SCBM≥3次/周的比例是42.55%,B组为29.17%,A组显著高于B组(P=0.013);A组SCBM增加≥1次/周的患者比例是61.70%,B组为43.75%,A组显著高于B组(P=0.004)。通过比较入组前及第4、6、12周PAC-QOL,加减四磨汤在改善CCSQ患者的生活质量方面明显优于普卢卡必利。最常见的不良反应是恶心、头痛、腹泻、腹痛,未出现明显的心血管事件。结论:CCSQ应用加减四磨汤安全、有效。展开更多
基金The study was approved by the Ethics Committee of Beijing Changping Hospital of Traditional and Western Medicine.
文摘BACKGROUND Depression is a widespread mental health condition that requires effective treatment.In the treatment of depression,traditional Chinese medicine(TCM)offers obvious advantages,fewer adverse reactions,and a lower recurrence rate.AIM To evaluate the clinical benefits of Guipi decoction combined with escitalopram oxalate tablets for individuals with depression.METHODS In total,80 patients diagnosed as having depression were enrolled in the study and divided into either an experimental group or a control group.All of the patients were orally administered escitalopram oxalate tablets.Additionally,the experimental group received Jiajian Guipi decoction and reduced Governor vessel fumigation over 4 wk.TCM syndrome scores,Hamilton depression rating scale(HAM-D)scores,self-rating depression scale(SDS)scores,and Pittsburgh sleep quality index scores were measured for the two groups and compared before and after the treatment.The two groups were monitored for any adverse reactions.RESULTS After 4 wk of treatment,both groups exhibited a significant reduction in TCM syndrome scores compared with their pre-treatment scores(P<0.05).However,the experimental group exhibited significantly lower TCM syndrome scores than the control group(P<0.05).Similarly,the post-treatment SDS and HAM-D-24 scores were significantly lower in both groups than the pre-treatment scores(P<0.05),with the experimental group exhibiting lower scores than the control group(P<0.05).The total treatment efficiency was significantly better in the experimental group(97.14%)than in the control group(77.78%)(P<0.05).Furthermore,after 4 wk of treatment,the Pittsburgh sleep quality index scores for both groups were significantly lower than those before the treatment(P<0.05),with the experimental group exhibiting lower scores than the control group(P<0.05).The incidence of adverse reactions was significantly lower in the experimental group than in the control group(P<0.05).CONCLUSION The combination of Guipi decoction and escitalopram oxalate tablets was found to be an effective and safe treatment for depression.This combination could reduce TCM syndrome scores,improve depressive symptoms,and enhance sleep quality.
文摘目的:观察加减四磨汤治疗慢性便秘气滞型(Chronic Constipation of Stagnation of QI,CCSQ)的疗效和安全性。方法:将95例CCSQ患者随机分成A组(加减四磨汤治疗组),B组(普卢卡必利对照组),首要观察12周治疗后自然完全排便次数(Spontaneous,Complete Bowel Movements,SCBM)≥3次/周的比例,次要观察SCBM增加≥1次/周的患者比例,并比较入组前及第4、6、12周便秘患者生活质量量表(Patient Assessment of Constipation Quality of Life,PAC-QOL)。同时记录不良事件。结果:在12周的疗程中,A组SCBM≥3次/周的比例是42.55%,B组为29.17%,A组显著高于B组(P=0.013);A组SCBM增加≥1次/周的患者比例是61.70%,B组为43.75%,A组显著高于B组(P=0.004)。通过比较入组前及第4、6、12周PAC-QOL,加减四磨汤在改善CCSQ患者的生活质量方面明显优于普卢卡必利。最常见的不良反应是恶心、头痛、腹泻、腹痛,未出现明显的心血管事件。结论:CCSQ应用加减四磨汤安全、有效。